Rhophilin-2 inhibitors, also known as RHPN2 inhibitors, encompass a diverse class of chemical agents designed to modulate the activity of RHPN2, a member of the Rhophilin family of proteins that interact with Rho GTPases, which play a critical role in the regulation of the actin cytoskeleton and in cellular signaling pathways. These inhibitors are characterized by their ability to interfere with the RHPN2 protein or its associated pathways by various molecular mechanisms. One method by which these inhibitors operate is through the inhibition of the RhoA signaling pathway. RhoA is a small GTPase that, when activated, engages with a variety of downstream effectors to bring about changes in actin cytoskeleton dynamics, cell motility, and other cellular functions. By targeting the inactive form of RhoA or its downstream effectors, such as Rho-associated protein kinases (ROCKs), these chemicals can impede the pathway at different junctures. This obstruction can lead to alterations in cellular processes that are normally influenced by the active RhoA-RHPN2 interaction.
Furthermore, RHPN2 inhibitors can act on the cytoskeletal architecture by directly targeting actin dynamics. Compounds that interact with actin monomers or filaments can prevent their polymerization or depolymerization, which are pivotal for cell shape, motility, and division. Inhibition of myosin light-chain kinase (MLCK) is another avenue through which these inhibitors can exert their effect. MLCK plays a vital role in actin-myosin contractility, and its inhibition can affect cellular events that require myosin's contractile capabilities. Additionally, the modulation of small GTPases like Rac1 is another strategy employed by RHPN2 inhibitors. As Rac1 is involved in the regulation of cell migration and adhesion, the inhibitors that target Rac1 can alter the normal RHPN2-mediated signaling events. Through these various mechanisms, RHPN2 inhibitors can influence the organization and function of the actin cytoskeleton, thereby affecting the cellular dynamics that are essential for the maintenance of cellular integrity and function. These inhibitors are valuable tools in the study of cell biology, as they help to dissect the complex signaling networks that govern cellular behavior.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SCIO 469 hydrochloride | 309913-83-5 | sc-361353 sc-361353A | 10 mg 50 mg | $205.00 $865.00 | 2 | |
CCG-1423 prevents the nuclear accumulation of MRTF, a coactivator of serum response factor (SRF), downstream of RhoA signaling, which could possibly inhibit RHPN2 by affecting gene expression related to its function. | ||||||
Fasudil, Monohydrochloride Salt | 105628-07-7 | sc-203418 sc-203418A sc-203418B sc-203418C sc-203418D sc-203418E sc-203418F | 10 mg 50 mg 250 mg 1 g 2 g 5 g 10 g | $18.00 $32.00 $85.00 $165.00 $248.00 $486.00 $910.00 | 5 | |
Fasudil, a ROCK inhibitor, could possibly inhibit RHPN2 by affecting stress fiber formation and cell adhesion through the RhoA signaling pathway. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $260.00 $799.00 | 36 | |
Latrunculin A binds to actin monomers and prevents their polymerization, which could possibly inhibit RHPN2 by disrupting the cytoskeleton and modulating cell dynamics. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $71.00 $260.00 $485.00 $949.00 | ||
Blebbistatin inhibits myosin II ATPase activity and could possibly inhibit RHPN2 by affecting cellular functions involved in stress fiber dynamics. | ||||||